<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04031625</url>
  </required_header>
  <id_info>
    <org_study_id>AB2012CR</org_study_id>
    <nct_id>NCT04031625</nct_id>
  </id_info>
  <brief_title>Metastatic Colorectal Cancer Database</brief_title>
  <official_title>Prospective and Retrospective Metastatic Colorectal Cancer Database</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Georges Francois Leclerc</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Georges Francois Leclerc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The metastatic ColoRectal Cancer (mCRC) Database base contains data collected during the
      regular clinical patient management in Centre Georges Francois Leclerc, Dijon.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The metastatic ColoRectal Cancer (mCRC) Database base contains data collected during the
      regular clinical patient management (sociodemographic, clinical, pathological, radiological,
      biological, disease evolution, ...). This database allows easy access to information in a
      centralized and structured way. This cohort is used to gather insights for research purposes.

      All data collected come from medical files of patients managed at Centre Georges Francois
      Leclerc, Dijon, France.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 26, 2012</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Patient survival</measure>
    <time_frame>2 years</time_frame>
    <description>Overall survival and evolution over years</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Collection of patient and treatment characteristics</measure>
    <time_frame>2 years</time_frame>
    <description>Collection of patient and treatment characteristics over years, to set up prospective and retrospective studies</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Metastatic Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Metastatic Colorectal Cancer</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Metastatic Colorectal Cancer Database</intervention_name>
    <description>Metastatic Colorectal Cancer Database</description>
    <arm_group_label>Metastatic Colorectal Cancer</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Regular clinical metastatic colorectal patient management in Centre Georges Fran√ßois
        Leclerc, Dijon
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Metastatic colorectal cancer

          -  Age &gt;= 18

        Exclusion Criteria:

          -  Non metastatic colorectal cancer

          -  Objection to the use of medical data records
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Methodology, Biostatistics and Data Management</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>AURELIE BERTAUT, MD, PhD</last_name>
      <phone>+33 3 80 73 77 84</phone>
      <email>ABertaut@cgfl.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 1, 2019</study_first_submitted>
  <study_first_submitted_qc>July 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 24, 2019</study_first_posted>
  <last_update_submitted>July 23, 2019</last_update_submitted>
  <last_update_submitted_qc>July 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Metastatic Colorectal Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

